Kernel is a Biotech company. It has raised $100M in total funding. Latest round: Series C. Backed by Bryan Johnson.
Kernel funding overview
Kernel is a Biotech company. Kernel has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2020. The round record for Kernel runs through 2020; nothing later has been disclosed. Investors on record include Bryan Johnson.
Kernel at a glance
Total raised
$100M
Latest round
Series C
Latest round date
January 2020
Industry
Biotech
Notable investors
Bryan Johnson
Frequently asked about Kernel funding
How much has Kernel raised?
Kernel has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Kernel?
Bryan Johnson are named among the investors backing Kernel.
What was the latest Kernel funding round?
The most recent disclosed round is a Series C, announced in January 2020.
Where is Kernel based?
No headquarters location is disclosed for Kernel.
What sector does Kernel operate in?
Kernel is tracked under Biotech, with $100M in disclosed funding.
When did Kernel last raise?
The last disclosed Kernel round closed in January 2020 at Series C.
We update the Kernel record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
